Intended for US Healthcare Professionals Only

Important Safety Information » | Full Prescribing Information »

THE ONE-FOR-ALL HRIG SOLUTION

Trust KEDRAB–a Human Rabies Immune Globulin (HRIG) for all ages and sizes, all exposures and wound types, and all healthcare professionals involved in the treatment of potential rabies exposures*

COMPLETE HRIG
CARE

View KEDRAB study data establishing safety and effectiveness in adults and children

>

COMPLETE HRIG COVERAGE

Learn how KEDRAB provides adequate volume to infiltrate all wounds sizes and types

>

COMPLETE HRIG CONFIDENCE

Utilize essential product resources and program benefits to help fight against rabies and save lives

>
*Please see the full Prescribing Information for additional information on patients not previously vaccinated, administering HRIG up to and including seven days after the first dose of rabies vaccine, previously vaccinated patients and any patients with a history or increased risk of hypersensitivity.

Watch this video to learn more about post-exposure prophylaxis and the benefits of KEDRAB.
administer_vial-183_2

Learn step-by-step guidance and watch examples on how to properly administer KEDRAB.

Reference: 1. KEDRAB [package insert]. Fort Lee, NJ: Kedrion Biopharma Inc.; 2021.

SAME KEDRAB, IMPROVED PRODUCT PACKAGING

  • Enhanced color packaging for clear identification of 2mL and 10mL dosage options
  • User-friendly vertical barcodes on vials for easier scanning

New KEDRAB packaging, with distinctive vial sizes and colors, designed to reduce chances of error

Over the next several months, you can expect to start receiving KEDRAB® (Rabies Immune Globulin [Human]) with enhanced product packaging, as pictured above. Products with new packaging will be shipped when available, and after distributors' current supplies become depleted. As such, it is likely you may not receive both the new 2mL and 10mL product packaging at the same time.